Table 3.
Treatment-related adverse events.
| TOXICITY TYPE | ANY GRADE (G) | GRADE ≤2 | GRADE 3 | GRADE 4 |
|---|---|---|---|---|
| Any event n(%) | 25 (86) | 13 (45) | 7 (24) | 3* (10) |
| Clinical adverse events | ||||
| Fatigue | 10 (35) | 9 (31) | 1 (3,5) | |
| Diarrhea | 6 (20) | 6 (20) | ||
| Hand foot syndrome | 6 (20) | 4 (14) | 2 (7) | |
| Rash | 5 (17) | 3 (10) | 1 (3,5) | 1*(3,5) |
| Anorexia | 4 (14) | 4 (14) | ||
| Oral mucositis | 4 (14) | 4 (14) | ||
| Muscle pain | 3 (10) | 3 (10) | ||
| Abdominal pain | 3 (10) | 3 (10) | ||
| Voice changes | 3 (10) | 3 (10) | ||
| Bleed | 2 (7,0) | 1 (3,5) | 1*(3,5) | |
| Nausea/Vomiting | 1 (3,5) | 1 (3,5) | ||
| Hypertension | 1 (3,5) | 1 (3,5) | ||
| Heart failure | 1 (3,5) | 1*(3,5) | ||
| Laboratory abnormalities | ||||
| Thrombocytopenia | 5 (17) | 3 (10) | 2 (7,0) | |
| Neutropenia | 3 (10) | 2 (7,0) | 1 (3,5) | |
| Anemia | 1 (3,5) | 1 (3,5) |
Note:
*
Hospitalization due to severe adverse events.